
- /
- Supported exchanges
- / US
- / RVPH.NASDAQ
Reviva Pharmaceuticals Holdings Inc. (RVPH NASDAQ) stock market data APIs
Reviva Pharmaceuticals Holdings Inc. Financial Data Overview
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Reviva Pharmaceuticals Holdings Inc. data using free add-ons & libraries
Get Reviva Pharmaceuticals Holdings Inc. Fundamental Data
Reviva Pharmaceuticals Holdings Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -10 103 922
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.1825
Get Reviva Pharmaceuticals Holdings Inc. End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Reviva Pharmaceuticals Holdings Inc. News

Reviva Pharmaceuticals holdings announces pricing of $10M public offering
* Reviva Pharmaceuticals Holdings (NASDAQ:RVPH [https://seekingalpha.com/symbol/RVPH]) on Thursday announced the pricing of its public offering with existing and new healthcare focused institutional...


Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
CUPERTINO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapie...

Reviva Pharmaceuticals stock falls after announcing public offering
Investing.com -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) stock tumbled 23.4% after the late-stage pharmaceutical company announced its intention to offer shares of common stock and warrant...

Reviva Pharmaceuticals announces public offering of common stock
CUPERTINO, Calif. - Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH), a pharmaceutical company with a market capitalization of $35.6 million, announced today its intention to offer shares of common...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.